Pharma news
Pharma
The English High Court has dismissed an application by Eli Lilly to stop Human Genome Sciences from getting an SPC based on a marketing authorisation Lilly may receive for a new drug. 23 July 2014
Pharma
The England and Wales High Court has refused Pfizer subsidiary Pharmacia’s request to stay Actavis’s patent revocation action against it. 17 July 2014
Asia
The Mumbai High Court has upheld India-based Natco Pharma’s compulsory licence on Bayer’s kidney cancer drug Nexavar (sorafenib). 16 July 2014
Americas
The Canadian government has responded to Eli Lilly’s complaint that recent decisions to invalidate two Lilly patents violated the North American Free Trade Agreement, saying that Lilly’s challenge is “wholly without merit”, and should be dismissed. 15 July 2014
Americas
Pfizer is facing three class actions that allege the pharmaceutical company improperly obtained a patent covering its arthritis drug Celebrex (celecoxib) and used it to force generic drug makers into settlements that delay their entry into the market, Law360 has reported. 10 July 2014
Americas
French pharmaceutical company Sanofi has sued Eli Lilly for infringing seven patents that cover its blockbuster diabetes drug Lantus (insulin glargine). 10 July 2014
Americas
Pfizer has launched a lawsuit against Aurobindo Pharma accusing the Indian pharmaceutical company of infringing patents related to an antibiotic used to treat skin infections. 4 July 2014
Americas
Actavis’s newly-acquired subsidiary Forest Laboratories has bought drug development company Furiex Pharmaceuticals for $1.1 billion. 3 July 2014
Americas
The head of IP at a major pharmaceutical company is set to be named as the next director of the US Patent and Trademark Office, reports have claimed. 2 July 2014
Americas
The Indian Patent Office has rejected a patent application for an anti-cancer drug for the second time, paving the way for generic versions to potentially enter the market. 24 June 2014